Supernus Pharmaceuticals Inc Long-term Investment Intensity

Latest as of March 2024: 0.9%

Supernus Pharmaceuticals Inc long-term investment intensity. Supernus Pharmaceuticals Inc (SUPN) has a Long-term Investment Intensity of 0.9% as of March 2024. Long-term investments of $11.66 Million represent 0.9% of total assets of $1.30 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital position of Supernus Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.

LT Investment Intensity

0.9%
LT Investments / Total Assets

Long-term Investments

$11.66 Million
USD

Total Assets

$1.30 Billion
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Supernus Pharmaceuticals Inc (2013–2023)

Long-term investment intensity of Supernus Pharmaceuticals Inc from 2013 to 2023. This chart shows how Supernus Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 11 annual periods from 2013 to 2023. As of March 2024, the intensity stands at 0.9%, reflecting long-term investments of $11.66 Million against total assets of $1.30 Billion USD. See defensive interval ratio of Supernus Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.

Supernus Pharmaceuticals Inc Long-term Investment Intensity by Year (2013–2023)

Supernus Pharmaceuticals Inc long-term investment intensity by year from 2013 to 2023. The table below presents the year-by-year Long-term Investment Intensity for Supernus Pharmaceuticals Inc from 2013 to 2023, covering 11 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Supernus Pharmaceuticals Inc total assets.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2023 1.3% $16.62 Million $1.28 Billion ▼ -4.2 pp
2022 5.5% $93.90 Million $1.70 Billion ▼ -1.5 pp
2021 7.1% $119.17 Million $1.69 Billion ▼ -16.2 pp
2020 23.3% $350.36 Million $1.50 Billion ▼ -27.7 pp
2019 51.0% $591.77 Million $1.16 Billion ▲ +8.2 pp
2018 42.8% $418.80 Million $977.81 Million ▲ +11.3 pp
2017 31.5% $133.64 Million $424.46 Million ▲ +7.1 pp
2016 24.4% $75.41 Million $309.57 Million ▼ -4.8 pp
2015 29.1% $55.01 Million $188.73 Million ▲ +14.7 pp
2014 14.4% $19.82 Million $137.51 Million ▲ +6.5 pp
2013 7.9% $8.76 Million $111.00 Million —
pp = percentage points